drugset / Trial / NCT00685737

Safety of a Hypolipidemic Agent in Healthy Normal Volunteers

NCT00685737

Phase 1 Completed 20 enrolled Pharmena North America
RandomizedCrossoverDouble-blindTreatment

Summary

The Purpose of this study is to determine the safety and tolerability of 1-MNA, a drug that is intended to be used in the treatment of elevated levels of blood fats. This study will determine the way that 1-MNA is handled by the body, and will also determine its effect on commonly measured blood fat parameters.

Timeline

Start
2007-12
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator TRIGONELLAMIDE Small molecule Oral

Indications